We demonstrated recently that although widely expressed in all clinical subtypes of breast cancer, TLR9 expression has significant, prognostic significance only in TNBC that lack the expression of estrogen (ER), progesterone (PR), and HER2 receptors. The gene discussed is TLR9; the disease is breast carcinoma.